ZAS Pharma Ltd. is a global specialty pharmaceutical company connecting manufacturers and markets through strategic licensing, regulatory expertise, and commercialization excellence. With a presence in 80+ countries, 400+ Marketing Authorizations, and a pipeline of 200+ MAs in specialty and niche products, we focus on biosimilars, oncology, rare diseases, critical care, blood derivatives, antivirals, and recombinant products. Through international partnerships, regulatory coordination, quality assurance, and tailored market access solutions, we help pharmaceutical partners expand globally and improve access to specialized medicines.